Experiences maintaining hair on alfatradiol?
    7/5/2026

    From the encyclopedia
    Finasteride →

    Frontline, gold standard treatment for combatting androgenic alopecia

    Alfatradiol →

    a synthetic estrogen used topically as an anti-androgen

    Minoxidil →

    An essential vasodilator with some anti-androgenic effects

    At a glance
    In this treatment experience post, the primary subjects mentioned are
    💊 Finasteride (oral) 0.25 mg every other day 10 months
    💧 Alfatradiol (topical)
    💧 Minoxidil (topical)
    the tone is 😐 neutral with hair loss stabilized results.

    Other terms

    The conversation is about maintaining hair after stopping finasteride due to side effects like gynecomastia. Alternatives discussed include alfatradiol, topical finasteride, and minoxidil.
    View this post in the Community →

    Similar Community Posts Join

    5 / 5 results

      community Anyone who used RU58841 without fin/dut?

      in Product  1 upvotes 1 year ago
      RU58841 was used by some for hair loss, but concerns about side effects like gynecomastia and safety were raised. Alternatives like finasteride, minoxidil, pyrilutamide, and alfatradiol were discussed, with some users reporting better experiences with these treatments.

      community Dutasteride Mesotherapy or Oral Finasteride

       4 upvotes 5 years ago
      A user is considering dutasteride mesotherapy versus oral finasteride for hair loss, with concerns about side effects. Other users share experiences with both treatments, suggesting oral finasteride as more effective and cost-efficient, while also discussing the use of minoxidil, alfatradiol, and potential side effects like gynecomastia.

      community What is everyone's assessment of pyrilutamide 1.0% topical as a adjunct treatment?

       5 upvotes 3 months ago
      The conversation discusses the use of pyrilutamide as an adjunct treatment for hair loss, particularly for those already using finasteride and minoxidil. Users share mixed experiences, with some reporting side effects like numbness and gynecomastia, while others note its potential benefits in reducing shedding and scalp itchiness.

      community Hair loss journey and experience with Fin/Min/Dut

       671 upvotes 11 months ago
      The user shared their hair loss journey, using finasteride, dutasteride, and minoxidil, noting progress and some side effects like minor gynecomastia. They plan to switch fully to dutasteride while continuing minoxidil, and they experienced shedding primarily from finasteride.

    Related Research

    6 / 6 results
      Finasteride Treatment of Hair Loss in Women

      research Finasteride Treatment of Hair Loss in Women

      29 citations , May 2010 in “Annals of Pharmacotherapy”
      This review discusses the limited objective evidence for using finasteride in women with alopecia, suggesting that it could be considered for those who don't benefit from minoxidil, but reports no new clinical results.
      Androgenetic Alopecia: Drug Safety and Therapeutic Strategies

      research Androgenetic alopecia; drug safety and therapeutic strategies

      20 citations , January 2018 in “Expert Opinion on Drug Safety”
      This review discusses androgenetic alopecia management with 5α-reductase inhibitors, emphasizing that while dutasteride shows superior efficacy, finasteride is suggested as preferable due to predictable adverse effects and preservation of physiological roles.
      Androgenetic Alopecia: An Evidence-Based Treatment Update

      research Androgenetic Alopecia: An Evidence-Based Treatment Update

      151 citations , May 2014 in “American Journal of Clinical Dermatology”
      This review concluded that oral finasteride for men and topical minoxidil for both genders have the most evidence supporting their effectiveness and safety for treating androgenetic alopecia.
      Female Pattern Alopecia: Current Perspectives

      research Female pattern alopecia: current perspectives

      42 citations , August 2013 in “International Journal of Women's Health”
      This review discusses the current therapeutic options for female pattern hair loss and emphasizes the need for managing patient expectations of permanent regrowth, reporting no new clinical results.